SK Bioscience Co Ltd Free Cash Flow Generation Index

Latest as of September 2025: -2.44x

SK Bioscience Co Ltd free cash flow generation index. SK Bioscience Co Ltd (302440) has a Free Cash Flow Generation Index of -2.44x as of September 2025. Free cash flow of ₩-50.29 Billion represents -2% of operating cash flow (₩20.65 Billion).

FCF Generation Index

-2.44x
Free Cash Flow / Operating CF

Free Cash Flow

₩-50.29 Billion
KRW

Operating Cash Flow

₩20.65 Billion
KRW

Capital Expenditures

₩70.94 Billion
KRW

Free Cash Flow Generation Index of SK Bioscience Co Ltd (2018–2023)

Free cash flow generation index of SK Bioscience Co Ltd from 2018 to 2023. Historical FCF Generation Index trend for SK Bioscience Co Ltd across 5 annual periods. See SK Bioscience Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.

SK Bioscience Co Ltd Free Cash Flow Generation Index by Year (2018–2023)

SK Bioscience Co Ltd free cash flow generation index by year from 2018 to 2023. Year-by-year Free Cash Flow Generation Index for SK Bioscience Co Ltd. For the full cash flow conversion analysis, see SK Bioscience Co Ltd (302440) cash conversion ratio.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2023 -0.71x ₩-20.95 Billion ₩29.35 Billion ₩50.30 Billion ▼ -177.8%
2021 0.92x ₩492.12 Billion ₩536.59 Billion ₩42.91 Billion ▲ +0.2%
2020 0.92x ₩110.03 Billion ₩120.22 Billion ₩9.93 Billion ▲ +594.7%
2019 -0.19x ₩-4.04 Billion ₩21.82 Billion ₩23.97 Billion ▼ -132.1%
2018 0.58x ₩8.59 Billion ₩14.90 Billion ₩6.31 Billion —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).